Table 3 Patient demographics and Clostridium difficile-infection related outcomes
| Â | WellStar | Florida |
|---|---|---|
Patient characteristics | N = 36 | N = 28 |
Age | 68.6 ± 16.7 | 82 ± 10.2 |
Gender: Male | 18 (50%) | 14 (50%) |
Race | ||
 Caucasian | 22 (61%) | 23 (82%) |
 African American | 5 (14%) | 1 (3.0%) |
 Other | 9 (25%) | 4 (14%) |
Admission source | ||
 Community | 27 (75%) | 15 (57%) |
 Other healthcare facility | 9 (25%) | 12 (43%) |
Previous hospitalization | 5 (14%) | 17 (61%) |
Episode | ||
 Initial episode | 32 (89%) | 20 (71%) |
 First recurrence | 4 (11%) | 6 (21%) |
 > 2 recurrences | NA | 2 (7%) |
CDAD present within 24Â h | 15 (42%) | 17 (61%) |
Top comorbidities | ||
 Moderate to severe renal disease | 20 (56%) | 6 (18%) |
 Diabetes | 19 (53%) | 9 (27%) |
 Cardiovascular disease | 17 (47%) | 15 (54%) |
Fidaxomicin treatment (days) | 8.4 ± 3.6 | 7.9 ± 5.2 |
Outcomes | ||
 Pathway adherence | 36/120 (30%) | 28/142 (20%) |
 Recurrence 30 day | 0 | 2 (7%) |
 Recurrence 60 day | 0 | 3 (9.7%) |
 Readmission | 5 (14%) | 6 (21%) |
 Readmission related to CDAD | 0 | 3 (50%) |
 Clinical cure | 30 (83%) | 26 (93%) |